Kalms Group and Intralink join forces to help medtech firms expand globally
Published on: April 7, 2022
Published on: April 7, 2022
South Korea: big opportunities for digital health firms
Published on: April 5, 2022
Web-Dialog: Der klinische Mehrwert der schnellen Genomsequenzierung in der Kinderintensivmedizin
Published on: February 16, 2022
Web-Dialog: Die klinische Befundung von Daten aus der Genomsequenzierung
Published on: November 4, 2021
The In Vitro Diagnostic Regulation (IVDR): Impact on Market Access in the European Union
Published on: October 11, 2021
BREXIT and the supply of medical devices: if you’re not prepared, take action now
Published on: July 27, 2021
Kalms Group establishes Advisory Board
Published on: June 16, 2021
Kalms Consulting – registered at EUDAMED database as an Economic Operator
Published on: June 5, 2021
Workshop: Medical Device Advertising – Compliance Aspects
Published on: April 20, 2021
Web-Dialog: Seltene Erkrankungen und Genomsequenzierung
Published on: April 14, 2021
